Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Breast Neoplasms | 10 | 2019 | 3633 | 1.23 | Why? |
| Adiposity | 2 | 2018 | 329 | 1.14 | Why? |
| Neoplasm Recurrence, Local | 5 | 2019 | 1063 | 1.10 | Why? |
| Mastectomy | 3 | 2019 | 536 | 0.78 | Why? |
| Tissue Expansion Devices | 1 | 2018 | 21 | 0.78 | Why? |
| Ketorolac | 1 | 2018 | 8 | 0.77 | Why? |
| Breast Implantation | 1 | 2018 | 23 | 0.77 | Why? |
| Controlled Clinical Trials as Topic | 1 | 2018 | 53 | 0.72 | Why? |
| Soft Tissue Neoplasms | 1 | 2018 | 131 | 0.65 | Why? |
| Intraoperative Care | 1 | 2018 | 238 | 0.65 | Why? |
| Testosterone | 2 | 2018 | 596 | 0.60 | Why? |
| Healthy Lifestyle | 1 | 2020 | 447 | 0.60 | Why? |
| Sarcoma | 1 | 2018 | 290 | 0.57 | Why? |
| Mammaplasty | 1 | 2018 | 224 | 0.57 | Why? |
| Social Networking | 1 | 2020 | 737 | 0.52 | Why? |
| Body Mass Index | 5 | 2018 | 4306 | 0.51 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.49 | Why? |
| Epidemiological Monitoring | 2 | 2021 | 3493 | 0.43 | Why? |
| Receptors, Estrogen | 4 | 2018 | 171 | 0.41 | Why? |
| Kidney Neoplasms | 1 | 2018 | 832 | 0.40 | Why? |
| Disease-Free Survival | 3 | 2019 | 1654 | 0.37 | Why? |
| Feeding Behavior | 1 | 2020 | 1909 | 0.35 | Why? |
| Lymphocytes, Tumor-Infiltrating | 2 | 2018 | 130 | 0.34 | Why? |
| Neoplasm Metastasis | 4 | 2018 | 682 | 0.33 | Why? |
| Tumor Burden | 2 | 2019 | 369 | 0.33 | Why? |
| Postmenopause | 2 | 2018 | 160 | 0.32 | Why? |
| Postoperative Complications | 3 | 2018 | 5861 | 0.30 | Why? |
| Time Factors | 6 | 2019 | 31397 | 0.23 | Why? |
| Lymph Nodes | 2 | 2019 | 1060 | 0.23 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.22 | Why? |
| Neoplasm Staging | 2 | 2018 | 1999 | 0.22 | Why? |
| Proportional Hazards Models | 5 | 2018 | 6543 | 0.21 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.21 | Why? |
| Exercise | 1 | 2020 | 6771 | 0.20 | Why? |
| Italy | 10 | 2021 | 38444 | 0.20 | Why? |
| Euthyroid Sick Syndromes | 1 | 2021 | 150 | 0.20 | Why? |
| Risperidone | 1 | 2018 | 55 | 0.19 | Why? |
| Social Media | 1 | 2021 | 5798 | 0.19 | Why? |
| Biomarkers, Tumor | 2 | 2018 | 1314 | 0.18 | Why? |
| Sex Hormone-Binding Globulin | 1 | 2018 | 57 | 0.18 | Why? |
| Carcinoma, Lobular | 1 | 2018 | 62 | 0.18 | Why? |
| Lymphatic Metastasis | 2 | 2018 | 537 | 0.18 | Why? |
| Aripiprazole | 1 | 2018 | 60 | 0.18 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.18 | Why? |
| Premenopause | 1 | 2018 | 63 | 0.18 | Why? |
| Tertiary Lymphoid Structures | 1 | 2017 | 6 | 0.18 | Why? |
| Axilla | 1 | 2019 | 198 | 0.18 | Why? |
| Tympanic Membrane Perforation | 1 | 2017 | 5 | 0.17 | Why? |
| Osteosarcoma | 1 | 2018 | 83 | 0.17 | Why? |
| Dairying | 1 | 2017 | 46 | 0.17 | Why? |
| Neoplasms, Second Primary | 1 | 2018 | 100 | 0.17 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.17 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.17 | Why? |
| Transplantation, Autologous | 1 | 2018 | 364 | 0.17 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.16 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.16 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.16 | Why? |
| Staining and Labeling | 1 | 2017 | 169 | 0.16 | Why? |
| Milk | 1 | 2017 | 158 | 0.16 | Why? |
| Chemotherapy, Adjuvant | 1 | 2019 | 606 | 0.15 | Why? |
| Otitis Media | 1 | 2017 | 106 | 0.15 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.15 | Why? |
| Masticatory Muscles | 1 | 2014 | 5 | 0.15 | Why? |
| Unnecessary Procedures | 1 | 2017 | 175 | 0.14 | Why? |
| Bone Neoplasms | 1 | 2018 | 287 | 0.14 | Why? |
| Regression Analysis | 2 | 2018 | 2484 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Weight Gain | 1 | 2018 | 552 | 0.13 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.13 | Why? |
| Temporomandibular Joint Disorders | 1 | 2014 | 77 | 0.12 | Why? |
| Electromyography | 1 | 2014 | 278 | 0.12 | Why? |
| Hospitals, Teaching | 2 | 2020 | 1609 | 0.12 | Why? |
| Hematologic Tests | 1 | 2017 | 521 | 0.12 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.11 | Why? |
| Humidity | 1 | 2017 | 944 | 0.11 | Why? |
| Humans | 31 | 2021 | 930598 | 0.11 | Why? |
| Risk Factors | 7 | 2019 | 71621 | 0.11 | Why? |
| Middle Aged | 14 | 2020 | 270681 | 0.10 | Why? |
| Postpartum Hemorrhage | 1 | 2011 | 144 | 0.10 | Why? |
| Antipsychotic Agents | 1 | 2018 | 887 | 0.10 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Female | 21 | 2021 | 380317 | 0.10 | Why? |
| Forecasting | 2 | 2021 | 4492 | 0.10 | Why? |
| Aged | 8 | 2020 | 215776 | 0.09 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.09 | Why? |
| Prognosis | 8 | 2021 | 32490 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.08 | Why? |
| Nomograms | 1 | 2013 | 790 | 0.08 | Why? |
| Adult | 12 | 2019 | 244371 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Hemoglobins | 1 | 2011 | 958 | 0.07 | Why? |
| Risk Assessment | 3 | 2019 | 25439 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.07 | Why? |
| Hepatitis C, Chronic | 1 | 2013 | 973 | 0.07 | Why? |
| Emergency Medical Services | 1 | 2021 | 3557 | 0.07 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.06 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.06 | Why? |
| Liver Cirrhosis | 1 | 2013 | 1810 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Receptors, Steroid | 1 | 2000 | 31 | 0.05 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.05 | Why? |
| Triiodothyronine | 1 | 2021 | 201 | 0.05 | Why? |
| Thyrotropin | 1 | 2021 | 262 | 0.05 | Why? |
| Thyroxine | 1 | 2021 | 250 | 0.05 | Why? |
| Child | 5 | 2021 | 70012 | 0.05 | Why? |
| Receptors, Progesterone | 1 | 2018 | 76 | 0.05 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.05 | Why? |
| Hematoxylin | 1 | 2017 | 9 | 0.04 | Why? |
| Infant | 2 | 2018 | 30274 | 0.04 | Why? |
| Eosine Yellowish-(YS) | 1 | 2017 | 11 | 0.04 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.04 | Why? |
| Magnetic Resonance Imaging | 1 | 2014 | 6551 | 0.04 | Why? |
| Exudates and Transudates | 1 | 2017 | 92 | 0.04 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.04 | Why? |
| Atmosphere | 1 | 2017 | 103 | 0.04 | Why? |
| Receptor, ErbB-2 | 1 | 2018 | 267 | 0.04 | Why? |
| Coloring Agents | 1 | 2017 | 116 | 0.04 | Why? |
| Biopsy | 2 | 2017 | 2811 | 0.04 | Why? |
| Thyroid Gland | 1 | 2021 | 516 | 0.04 | Why? |
| Myocardial Infarction | 1 | 2012 | 3361 | 0.04 | Why? |
| Vitamin B 12 | 1 | 2017 | 132 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Folic Acid | 1 | 2017 | 172 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2017 | 9537 | 0.03 | Why? |
| Ferritins | 1 | 2017 | 2055 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2018 | 4758 | 0.02 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| France | 1 | 2020 | 12074 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Age Distribution | 1 | 2011 | 3567 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.01 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Liver | 1 | 2013 | 4007 | 0.01 | Why? |
| Biomarkers | 2 | 2012 | 23361 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Likelihood Functions | 1 | 2000 | 719 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2013 | 22971 | 0.01 | Why? |
| Pregnancy | 1 | 2011 | 23879 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Cohort Studies | 1 | 2011 | 36005 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2012 | 11497 | 0.00 | Why? |
| Aged, 80 and over | 1 | 2012 | 88759 | 0.00 | Why? |
Biganzoli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(94)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_